Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ROIVW ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)

Watchlist
1.8650.0000.00%
Trading Session  02/08 12:18 ET
High
0.000
Open
1.850
Turnover
2.00
Low
0.000
Pre Close
1.865
Volume
1.00
Market Cap
0
P/E(TTM)
0.00
52wk High
2.550
Shares
0
P/E(Static)
0.00
52wk Low
0.218
Float Cap
0
Bid/Ask %
-71.43%
Historical High
2.690
Shs Float
0
Volume Ratio
0.00
Historical Low
0.218
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
2.000
Lot Size
1
Float Cap
0
Bid/Ask %
-71.43%
Historical High
2.690
Shs Float
0
Volume Ratio
0.00
Historical Low
0.218
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
2.000
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
CEO: Mr. Matthew Gline
Market: NASDAQ
Listing Date: 12/14/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist